{
  "success": true,
  "pagesUsed": [
    0,
    1,
    2
  ],
  "modelUsed": "claude-opus-4-5",
  "metadata": {
    "studyName": "Efficacy and Safety of Tirzepatide Once Weekly in Participants without Type 2 Diabetes Who Have Obes",
    "titles": [
      {
        "id": "title_1",
        "text": "Efficacy and Safety of Tirzepatide Once Weekly in Participants without Type 2 Diabetes Who Have Obesity or are Overweight with Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)",
        "type": {
          "code": "Official Study Title",
          "codeSystem": "USDM",
          "decode": "Official Study Title"
        },
        "instanceType": "StudyTitle"
      },
      {
        "id": "title_2",
        "text": "Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who are either Obese or Overweight with Weight-Related Comorbidities (SURMOUNT-1)",
        "type": {
          "code": "Brief Study Title",
          "codeSystem": "USDM",
          "decode": "Brief Study Title"
        },
        "instanceType": "StudyTitle"
      },
      {
        "id": "title_3",
        "text": "SURMOUNT-1",
        "type": {
          "code": "Study Acronym",
          "codeSystem": "USDM",
          "decode": "Study Acronym"
        },
        "instanceType": "StudyTitle"
      }
    ],
    "identifiers": [
      {
        "id": "sid_1",
        "text": "NCT04184622",
        "scopeId": "org_unknown",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_2",
        "text": "I8F-MC-GPHK(b)",
        "scopeId": "org_unknown",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_3",
        "text": "LY3298176",
        "scopeId": "org_unknown",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_4",
        "text": "IND: 139721",
        "scopeId": "org_unknown",
        "instanceType": "StudyIdentifier"
      }
    ],
    "organizations": [
      {
        "id": "org_1",
        "name": "Eli Lilly and Company",
        "type": {
          "code": "Pharmaceutical Company",
          "codeSystem": "USDM",
          "decode": "Pharmaceutical Company"
        },
        "instanceType": "Organization"
      }
    ],
    "roles": [],
    "indications": [
      {
        "id": "ind_1",
        "name": "Obesity or Overweight with Weight-Related Comorbidities",
        "isRareDisease": false,
        "instanceType": "Indication",
        "description": "Participants without Type 2 Diabetes who have obesity or are overweight with weight-related comorbidities"
      }
    ],
    "studyPhase": {
      "code": "Phase3",
      "codeSystem": "USDM",
      "decode": "Phase3"
    },
    "studyType": "Interventional"
  },
  "rawResponse": {
    "titles": [
      {
        "id": "title_1",
        "text": "Efficacy and Safety of Tirzepatide Once Weekly in Participants without Type 2 Diabetes Who Have Obesity or are Overweight with Weight-Related Comorbidities: A Randomized, Double-Blind, Placebo-Controlled Trial (SURMOUNT-1)",
        "type": {
          "code": "OfficialStudyTitle",
          "codeSystem": "http://www.cdisc.org/USDM/titleType",
          "decode": "Official Study Title"
        },
        "instanceType": "StudyTitle"
      },
      {
        "id": "title_2",
        "text": "Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo in Participants Who are either Obese or Overweight with Weight-Related Comorbidities (SURMOUNT-1)",
        "type": {
          "code": "BriefStudyTitle",
          "codeSystem": "http://www.cdisc.org/USDM/titleType",
          "decode": "Brief Study Title"
        },
        "instanceType": "StudyTitle"
      },
      {
        "id": "title_3",
        "text": "SURMOUNT-1",
        "type": {
          "code": "StudyAcronym",
          "codeSystem": "http://www.cdisc.org/USDM/titleType",
          "decode": "Study Acronym"
        },
        "instanceType": "StudyTitle"
      }
    ],
    "identifiers": [
      {
        "id": "sid_1",
        "text": "NCT04184622",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_2",
        "text": "I8F-MC-GPHK(b)",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_3",
        "text": "LY3298176",
        "instanceType": "StudyIdentifier"
      },
      {
        "id": "sid_4",
        "text": "IND: 139721",
        "instanceType": "StudyIdentifier"
      }
    ],
    "organizations": [
      {
        "id": "org_1",
        "name": "Eli Lilly and Company",
        "type": {
          "code": "Sponsor",
          "codeSystem": "http://www.cdisc.org/USDM/organizationType",
          "decode": "Sponsor"
        },
        "instanceType": "Organization"
      }
    ],
    "studyPhase": {
      "code": "Phase3",
      "codeSystem": "http://www.cdisc.org/USDM/studyPhase",
      "decode": "Phase 3"
    },
    "studyType": "Interventional",
    "indication": {
      "id": "ind_1",
      "name": "Obesity or Overweight with Weight-Related Comorbidities",
      "description": "Participants without Type 2 Diabetes who have obesity or are overweight with weight-related comorbidities",
      "instanceType": "Indication"
    }
  }
}